2013 annual financial data
Avalo Therapeutics 2013 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -12,934,448 USD and net income was -13,045,008 USD.
Operating cash flow was -11,485,140 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -12,934,448 USD
- Net income
- -13,045,008 USD
- Operating cash flow
- -11,485,140 USD